Anti alpha - folate - receptor - tetramer antibodies

Details for Australian Patent Application No. 2004249673 (hide)

Owner Morphotek, Inc.

Inventors Nicolaides, Nicholas C.; Grasso, Luigi; Sass, Philip M.

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004249673

PCT Pub. Number WO2004/113388

Priority 60/472,940 23.05.03 US

Filing date 21 May 2004

Wipo publication date 29 December 2004

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

22 December 2005 PCT application entered the National Phase

  PCT publication WO2004/113388 Priority application(s): WO2004/113388

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004249675-Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

2004249671-Benzofuran inhibitors of factor VIIa